Your browser doesn't support javascript.
Maternity care provider acceptance of a future Group B Streptococcus vaccine - A qualitative study in three countries.
Geoghegan, Sarah; Acosta, Francia; Stephens, Laura C; Gillan, Hanah; Valera, Sandra; Drew, Richard J; Eogan, Maeve; Ratner, Adam J; Steenhoff, Andrew P; Butler, Karina M; Feemster, Kristen A.
  • Geoghegan S; Department of Paediatric Infectious Diseases and Immunology Children's Health Ireland at Crumlin & Temple Street, Dublin, Ireland; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; School of Medicine, University College Dublin, Dublin, Irel
  • Acosta F; Children's Hospital of Philadelphia Global Health Center, USA; Niños Primeros en Salud, Consuelo, Dominican Republic.
  • Stephens LC; School of Medicine, University College Dublin, Dublin, Ireland.
  • Gillan H; School of Medicine, University College Dublin, Dublin, Ireland.
  • Valera S; Hospital Materno Infantil San Lorenzo de Los Mina, Santo Domingo, Dominican Republic.
  • Drew RJ; Clinical Innovation Unit, The Rotunda Hospital, Dublin, Ireland; Irish Meningitis and Sepsis Reference Laboratory, Children's Health Ireland at Temple Street, Dublin, Ireland; Department of Microbiology, Royal College of Surgeons in Ireland, Dublin, Ireland.
  • Eogan M; Division of Obstetrics & Gynaecology, The Rotunda Hospital, Dublin, Ireland.
  • Ratner AJ; Division of Pediatric Infectious Diseases, Grossman School of Medicine, New York University, New York, NY, USA.
  • Steenhoff AP; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Children's Hospital of Philadelphia Global Health Center, USA.
  • Butler KM; Department of Paediatric Infectious Diseases and Immunology Children's Health Ireland at Crumlin & Temple Street, Dublin, Ireland; School of Medicine, University College Dublin, Dublin, Ireland.
  • Feemster KA; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA; Children's Hospital of Philadelphia Global Health Center, USA; Global Medical and Scientific Affairs, Merck Research Laboratories, Merck & Co., Inc, Upper Gwynedd, PA, USA.
Vaccine ; 41(12): 2013-2021, 2023 03 17.
Artigo em Inglês | MEDLINE | ID: covidwho-2240933
ABSTRACT

INTRODUCTION:

There are vaccines in clinical trials that target the bacterium Group B Streptococcus (GBS). When approved, GBS vaccines will be intended for administration to pregnant women to prevent infection in their infants. The success of any vaccine will depend on its' uptake in the population. Experience with prior maternal vaccines, e.g. influenza, Tdap and COVID-19 vaccines, teaches us that acceptance of vaccines, especially if novel, is challenging for pregnant women, and that provider recommendation is a key driver of vaccine uptake.

METHODS:

This study investigated attitudes of maternity care providers towards the introduction of a GBS vaccine in three countries (the United States (US), Ireland, and the Dominican Republic (DR)) with different GBS prevalence and prevention practices. Semi-structured interviews with maternity care providers were transcribed and coded for themes. The constant comparative method, and inductive theory building were used to develop conclusions.

RESULTS:

Thirty-eight obstetricians, 18 general practitioners and 14 midwives participated. There was variability in provider attitudes towards a hypothetical GBS vaccine. Responses ranged from enthusiasm to doubts over the need for a vaccine. Attitudes were influenced by perceived additional benefits of a vaccine over current strategy and confidence in the safety of vaccines during pregnancy. Knowledge, experience and approaches to GBS prevention differed geographically and according to provider type, and influenced how participants assessed the risks and benefits of a GBS vaccine.

CONCLUSION:

Maternity care providers are engaged in the topic of GBS management and there is opportunity to leverage attitudes and beliefs that will support a strong recommendation for a GBS vaccine. However, knowledge of GBS, and of the limitations of current prevention strategies vary among providers in different regions, and between different provider types. Targeted educational efforts with antenatal providers should focus on highlighting safety data the potential benefits of vaccination over current strategies.
Assuntos
Palavras-chave

Texto completo: Disponível Coleções: Bases de dados internacionais Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / COVID-19 / Serviços de Saúde Materna Tipo de estudo: Estudo observacional / Estudo prognóstico / Pesquisa qualitativa Tópicos: Vacinas Limite: Feminino / Humanos / Gravidez Idioma: Inglês Revista: Vaccine Ano de publicação: 2023 Tipo de documento: Artigo

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponível Coleções: Bases de dados internacionais Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / COVID-19 / Serviços de Saúde Materna Tipo de estudo: Estudo observacional / Estudo prognóstico / Pesquisa qualitativa Tópicos: Vacinas Limite: Feminino / Humanos / Gravidez Idioma: Inglês Revista: Vaccine Ano de publicação: 2023 Tipo de documento: Artigo